Information regarding the specific manufacturing locations for Keppra (levetiracetam) is not publicly available. Pharmaceutical companies typically do not disclose the exact sites where their drugs are produced for competitive and security reasons.
Who Makes Keppra?
Keppra is manufactured by UCB Pharma [1]. UCB is a global biopharmaceutical company headquartered in Brussels, Belgium [1].
When Does Keppra's Patent Expire?
The original patents for Keppra have expired, allowing for the development and marketing of generic versions of levetiracetam. However, specific patent expiry dates can vary by region and may be subject to additional patent protections or exclusivities. For detailed patent information, resources like DrugPatentWatch.com can provide specific timelines [2].
What are the Generic Alternatives to Keppra?
Following the patent expiry of Keppra, numerous generic manufacturers have entered the market, offering levetiracetam at a lower cost. These generic versions are therapeutically equivalent to the branded Keppra.
How is Levetiracetam Used?
Keppra (levetiracetam) is primarily used to treat partial-onset seizures in individuals with epilepsy [3]. It is also used for myoclonic seizures and generalized tonic-clonic seizures [3].
What are the Side Effects of Keppra?
Common side effects associated with Keppra include drowsiness, dizziness, fatigue, and behavioral changes such as aggression and mood disturbances [4]. Patients and healthcare providers monitor for these effects during treatment.
How is Keppra Manufactured?
The manufacturing process for pharmaceuticals like Keppra involves complex chemical synthesis and formulation steps performed under strict Good Manufacturing Practices (GMP) regulations. These processes ensure the drug's purity, potency, and safety. While the specific steps are proprietary, the active pharmaceutical ingredient (API) levotiracetam is synthesized, purified, and then combined with excipients to create the final dosage form (tablets, oral solution, or injectable solution) [5].
What is the Mechanism of Action for Levetiracetam?
Levetiracetam's exact mechanism of action is not fully understood. However, it is believed to modulate synaptic vesicle protein 2A (SV2A) in the brain, which is a protein found in synaptic vesicles and plays a role in regulating neurotransmitter release [3]. This action is thought to contribute to its anticonvulsant properties.
How Much Does Keppra Cost?
The cost of Keppra can vary significantly depending on factors such as insurance coverage, pharmacy, and whether a brand-name or generic version is purchased. Generic levetiracetam is generally considerably less expensive than the brand-name Keppra.
---
Sources:
[1] UCB Pharma. https://www.ucb.com/
[2] DrugPatentWatch.com. (This is a placeholder as the specific URL for Keppra patent information is not provided in the prompt.)
[3] Keppra Prescribing Information. (Specific prescribing information links are not provided in the prompt.)
[4] Mayo Clinic. https://www.mayoclinic.org/drugs-supplements/levetiracetam-oral-route-injection-route/side-effects/drh-20067400
[5] FDA Drug Approvals. (This is a placeholder as specific FDA approval documentation for Keppra manufacturing is not provided in the prompt.)